Emerald Advisers »

Corcept Therapeutics Incorporated shares owned by Emerald Advisers

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $19M 233k 83.11
2025-06-30 $18M 242k 73.40
2025-03-31 $7.1M 62k 114.22

More positions owned by Emerald Advisers

Kratos Defense & Security Solutions (KTOS)
Credo Technology Group Holding (CRDO)
AeroVironment (AVAV)
Rambus (RMBS)
Lumentum Hldgs (LITE)
TTM Technologies (TTMI)
Bloom Energy Corp (BE)
Modine Manufacturing (MOD)
Guardant Health (GH)
Varonis Sys (VRNS)
Travere Therapeutics (TVTX)
RadNet (RDNT)
Sitime Corp (SITM)
National Vision Hldgs (EYE)
Ban (TBBK)

View all positions for Emerald Advisers

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated